This study aim to ensure that the implementation of a paramedical screening program and counseling in sexual health of patients with neurological pathologies (low-grade gliomas and Multiple Sclerosis) improves their sexual health.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
54
Paramedical early detection of sexual dysfunction and sexual health counseling
Groupe Hospitalier Pitie Salpetriere
Paris, France
Change of MSISQ15 (Multiple Sclerosis Intimacy and Sexuality Questionnaire)
Change of MSISQ15 sexual dysfunctional items at 3-months from baseline
Time frame: Inclusion and 3 months
Change of MSISQ15 (Multiple Sclerosis Intimacy and Sexuality Questionnaire)
Change of MSISQ15 sexual dysfunctional items at 6-months from baseline
Time frame: Inclusion and 6-months
Change of HAD scale (Hospital Anxiety and Depression)
Change of HAD scale score at 3-months from baseline
Time frame: Inclusion and 3 months
Change of HAD scale (Hospital Anxiety and Depression)
Change of HAD scale score at 6-months from baseline
Time frame: Inclusion and 6 months
Change of Rosenberg's Self-esteem Scale
Change of Rosenberg's Self-esteem Scale score at 3-months from baseline
Time frame: Inclusion and 3 months
Change of Rosenberg's Self-esteem Scale
Change of Rosenberg's Self-esteem Scale score at 6-months from baseline
Time frame: Inclusion and 6 months
Change of Quality of life scale
Change of Quality of life scale score at 3-months from baseline
Time frame: Inclusion and 3 months
Change of Quality of life scale
Change of Quality of life scale score at 6-months from baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Inclusion and 6 months
Change of QLQ-C30/BM20 scale (Quality of Life Questionnaire - Core Questionnaire / Brain Module)
Change of QLQC30/BM20 score at 3-months from baseline
Time frame: Inclusion and 3 months
Change of QLQ-C30/BM20 scale (Quality of Life Questionnaire - Core Questionnaire / Brain Module)
Assessment of QLQC30/BM20 score at 6-months from baseline
Time frame: Inclusion and 6 months
Change of SEP59 scale (Sclérose En Plaques)
Change of SEP59 scale score at 3-months from baseline
Time frame: Inclusion and 3 months
Change of SEP59 scale (Sclérose En Plaques)
Change of SEP59 scale score at 6-months from baseline
Time frame: Inclusion and 6 months
Program satisfaction scale
Program satisfaction scale scores at 3-months
Time frame: 3 months
Program satisfaction scale
Program satisfaction scale scores at 6-months
Time frame: 6 months